SENS
Senseonics Holdings, Inc.
Set alert
9.51 USD -0.24 -2.46%
9.07 Day range 9.66
4.86 52-week range 10.34
- YTD
- +72.28%
- 1 year
- +31.90%
- Open
- 9.45
- Prev close
- 9.75
- Mkt cap
- 502.83M
- Vol
- 988.58K
- Avg vol
- 709.60K
- EPS
- -2.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.07
- High
- 9.66
- Forward P/E
- -3.94
- Beta
- 0.80
- Short ratio
- 8.29
- Inst. own
- 10.01%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.3394
- 200-d avg
- 0.410795
- 1y target
- 1.60
Key statistics
- Market cap
- 281.59M
- Enterprise value
- 295.80M
- Trailing P/E
- 0.00
- Forward P/E
- -3.94
- PEG ratio
- 0.00
- Price / sales
- 12.68
- Price / book
- 0.00
- EPS (TTM)
- -0.13
- Beta
- 0.80
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 22.20M
- Revenue growth
- -30.10%
- Free cash flow
- -39.06M
- Total cash
- 74.48M
- Total debt
- 60.14M
- Return on equity
- -145.80%
- Shares outstanding
- 595.33M
- Short % of float
- 7.14%
- 50-day average
- 0.3394
- 200-day average
- 0.410795
Analyst view
Consensus: hold
Hold
Price target (mean) 1.60 -83.2% downside
Now 9.51
- Target (low)
- 0.30
- Target (mean)
- 1.60
- Target (high)
- 2.50
Ratings (0m) 4 2 buy · 1 hold · 1 sell
- Strong buy1
- Buy1
- Hold1
- Sell1
- Strong sell0
Next earnings
Consensus EPS estimate -0.03.
Financials — quick view
SENS Revenue — quarterly 14.48M
SENS Net income — quarterly -36.70M
SENS EPS — quarterly -0.63
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.03 | -0.04 | -0.01 | -33.33% |
| Aug 8, 2024 | Jun 1, 2024 | -0.03 | -0.03 | 0.00 | 0.00% |
| May 13, 2024 | Mar 1, 2024 | -0.03 | -0.03 | 0.00 | 0.00% |
| Feb 29, 2024 | Dec 1, 2023 | -0.04 | -0.03 | +0.01 | +25.00% |
| Nov 9, 2023 | Sep 1, 2023 | -0.04 | -0.04 | 0.00 | 0.00% |
| Aug 10, 2023 | Jun 1, 2023 | -0.04 | -0.04 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 11, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 14, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 15, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Jul 19, 2023 | Jefferies | init | — | Underperform |
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- senseonics.com
News
- TD Cowen Reiterates Buy on Senseonics Holdings, Maintains $15 Price Target
- Senseonics Initiates First-In-Human Study Of Freedom
- Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component
- Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript
- Barclays Initiates Coverage On Senseonics Holdings with Equal-Weight Rating, Announces Price Target of $10
Your note
Sign in to keep a note on SENS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FIORENTINO EDWARD J | Director | Stock Award(Grant) | Sep 30, 2024 | 1,152,940 |
| GOODNOW TIMOTHY TODD | Chief Executive Officer | Purchase | Dec 9, 2024 | 11,310,400 |
| HORTON KENNETH L | Officer | Stock Award(Grant) | May 22, 2024 | 2,974,690 |
| JAIN MUKUL | Chief Operating Officer | Stock Award(Grant) | May 22, 2024 | 5,149,390 |
| KAUFMAN FRANCINE | Officer and Director | Stock Award(Grant) | May 22, 2024 | 2,429,150 |
| PRINCE DOUGLAS S | Director | Stock Award(Grant) | Sep 30, 2024 | 929,756 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.95% | 23,530,403 | 11.13M | Sep 29, 2024 |
| Blackrock Inc. | 1.38% | 8,196,859 | 3.88M | Sep 29, 2024 |
| Masters Capital Management, LLC | 1.18% | 7,000,000 | 3.31M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.98% | 5,838,396 | 2.76M | Sep 29, 2024 |
| Charles Schwab Investment Management, Inc. | 0.51% | 3,064,856 | 1.45M | Sep 29, 2024 |
| State Street Corporation | 0.32% | 1,890,515 | 894.21K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.21% | 13,150,746 | 6.22M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.33% | 7,942,373 | 3.76M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.51% | 3,050,264 | 1.44M | Oct 30, 2024 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.42% | 2,522,673 | 1.19M | Aug 30, 2024 |
| Vanguard Health Care Index Fund | 0.22% | 1,333,472 | 630.73K | Aug 30, 2024 |
| Fidelity Total Market Index Fund | 0.16% | 931,455 | 440.58K | Oct 30, 2024 |